SCHEMBL31386211

SCHEMBL31386211

COC(=O)c1ccc([C@@H]2CNCCO2)c(C)c1

nearest known ligand 0.47

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.45
CHRNB2 P17787 1/20 0.44
CHRNA4 P43681 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31385731 1.00 TAAR1 (0.45) TAAR1CHRNB2CHRNA4
SCHEMBL31386254 0.84 SLC6A2 (0.42) TAAR1
SCHEMBL31386209 0.84 SLC6A2 (0.42) TAAR1
SCHEMBL15613943 0.82 HPGD (0.50)
SCHEMBL31386143 0.81 CA12 (0.45) CHRNB2CHRNA4
SCHEMBL31385851 0.80
SCHEMBL27805833 0.80
SCHEMBL3236943 0.80 NPC1 (0.47)
SCHEMBL31385832 0.80 CHRNB2 (0.46) CHRNB2CHRNA4
SCHEMBL29318689 0.79 SLC6A3 (0.52) TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727591-A1 SMARCA2 DEGRADERS AND USES THEREOF Astrazeneca AB (SE) 2026-04-22 EP disclosed
WO-2024256988-A1 SMARCA2 DEGRADERS AND USES THEREOF ASTRAZENECA AB (SE) 2024-12-19 WO disclosed